The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial

Diabetes Research and Clinical Practice

Volumn 55, Issue 3, 2002, Pages 209-219

  Gerstein, Hertzel C ^a   Thorpe, Kevin E ^a   Wayne Taylor, D ^a   Brian Haynes, R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Hydroxychloroquine; Oral hypoglycemic agent; Therapy; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA INJURY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAZARD; HEALTH STATUS; HUMAN; HYPERGLYCEMIA; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYCHLOROQUINE; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; PLACEBOS; SULFONYLUREA COMPOUNDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036175209     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(01)00325-4     Document Type: Article

References (23)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
2. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with dia
3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
4. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
5. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependant diabetes mellitus. A new job for an old drug?
6. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis
7. Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus
8. Effect of chloroquine on insulin and glucose homeostasis in normal subjects and patients with non-insulin dependent diabetes mellitus
9. Hypoglycemia induced by hydroxychloroquine in a type II diabetic treated for polyarthritis
10. The validity of self-reported exercise-induced sweating as a measure of physical activity
11. Analytical and semi-preparative high performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers
12. The sickness impact profile: development and final revision of a health status measure
13. Measurement of health status in diabetic patients
14. Utility approach to measuring health-related quality of life
15. Ophthalmologic monitoring of patients taking antimalarials: preferred practice patterns
16. Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus
17. Hepatic processing of insulin. Characterization of differential inhibition by weak bases
18. Lysosomal degradation of receptor-bound 125I-labeled insulin by rat adipocytes: its characterization and dissociation from the short-term biologic effects of insulin
19. Separate intracellular pathways for insulin receptor recycling and insulin degradation in isolated rat adipocytes
20. Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent
21. Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats
22. Antimalarials